Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

28d ago, source: InvestingChannel on MSN

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript March 18, 2024 Acurx Pharmaceuticals, Inc. isn't ...

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

26d ago, source: Business Insider

Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the ...

Acurx Pharmaceuticals: Strong Buy on Ibezapolstat’s Promising Phase 3 Trials and Strategic Partnerships

28d ago, source: Business Insider

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Acurx Pharmaceuticals (ACXP – Research Report) today and set a price target of $12.00. Ed Arce has given his Buy rating due to a ...

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

29d ago, source: Finanznachrichten

STATEN ISLAND, N.Y., March 18, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical stage biopharmaceutical ...

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

28d ago, source: Insider Monkey

Acurx Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the Acurx ...

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

26d ago, source: Stockhouse

Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the ...

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

29d ago, source: Yahoo Finance

STATEN ISLAND, N.Y., March 18, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of ...

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript

28d ago, source: Seeking Alpha

Greetings and welcome to the Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Earnings Results and Business Update Call. At this time, all participants are in a listen only mode.

Q4 2023 Acurx Pharmaceuticals Inc Earnings Call

28d ago, source: Yahoo Finance

David P. Luci; Co-Founder, President, CEO & Director; Acurx Pharmaceuticals, Inc. Robert G. Shawah; Co-Founder & CFO; Acurx Pharmaceuticals, Inc. Robert J. DeLuccia ...